(Received for publication, September 23, 1996, and in revised form, December 8, 1996)
From the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
The specific formylation of initiator
methionyl-tRNA by methionyl-tRNA formyltransferase (MTF) is important
for initiation of protein synthesis in Escherichia coli. In
attempts to identify regions of MTF that come close to the 3-end of
the tRNA, we oxidized 32P-3
-end-labeled E. coli initiator methionine tRNA with sodium metaperiodate and
cross-linked it to MTF. The cross-linked MTF was separated from
uncross-linked MTF by DEAE-cellulose chromatography, and the tRNA in
the cross-linked MTF was hydrolyzed with nuclease P1 and RNase T1,
leaving behind an oxidized fragment of [32P]AMP attached
to MTF. Trypsin digestion of the cross-linked MTF followed by high
pressure liquid chromatography of the digest yielded two peaks of
radioactive peptides, I* and II*. These peptides were characterized by
N- and/or C-terminal sequencing and by matrix-assisted laser desorption
ionization mass spectroscopy. Peptide I* contained amino acids
Gln186-Lys210 with Lys207 as the
site of the cross-link. Peptide II*, a partial digestion product,
contained amino acids Gln186-Arg214 also with
Lys207 as the site of the cross-link. The molecular masses
of peptides I* and II* indicate that the final product of the
cross-linking reaction between the periodate-oxidized AMP moiety of the
tRNA and Lys207 is most likely a morpholino derivative
rather than a reduced Schiff's base.
From assembly and packaging of RNA viruses (1) to mRNA localization during development (2), the specific recognition of RNAs by proteins plays an important role in many biological processes. Examples of these biological processes include RNA processing, RNA splicing, RNA transport, ribosome assembly, translation, and translational regulation (3). As molecules that interact with a variety of different proteins, tRNAs provide an excellent system for studying the molecular basis of specificity in recognition of RNAs by different proteins (4).
We are studying the specific recognition of Escherichia coli
initiator methionyl-tRNA (Met-tRNA),1
during its formylation to formylmethionyl-tRNA by the enzyme methionyl-tRNA formyltransferase (MTF, EC 2.1.2.9;
10-formyltetrahydrofolate:L-methionyl-tRNA N-formyltransferase). Formylation of initiator Met-tRNA is
important for initiation of protein synthesis in eubacteria and in
eukaryotic organelles such as mitochondria and chloroplasts (5-9). In
E. coli, formylation provides a positive determinant for
allowing the initiation factor IF2 to select the initiator tRNA from
other tRNAs (10, 11) and a second negative determinant for blocking the
binding of elongation factor EF-Tu to the initiator tRNA (12-14). The
formylation reaction is highly specific; the enzyme formylates the
initiator Met-tRNA but not the elongator Met-tRNA or any other aminoacyl-tRNA (15). Previous studies have shown that most of the
determinants on the initiator tRNA important for its formylation by MTF
are clustered in the acceptor stem (16-19) (Fig. 1).
However, although the protein sequence of MTF is known (20), little is known about the amino acid residues in MTF that are important for this
recognition and the molecular basis of the specificity in
recognition.
As a first step in identifying regions of MTF that come close to the
acceptor stem of the tRNA, we have cross-linked periodate-oxidized tRNA
to MTF and have analyzed the site(s) of cross-linking. We show that
Lys207 in the sequence KLSKE (207-211) of MTF is the site
of cross-link to the 3 terminus of the
tRNA.2 The cross-linking of
periodate-oxidized E. coli tRNAfMet to MTF has
been studied before by Blanquet and co-workers (21). However, the sites
of cross-linking were not analyzed in the previous work.
Sodium
metaperiodate, folinic acid, carboxypeptidase Y (sequencing grade), and
methionine were obtained from Sigma. Sodium borohydride, sodium
cyanoborohydride, and -cyano-4-hydroxycinnamic acid were purchased
from Aldrich. E. coli tRNA nucleotidyltransferase and
E. coli methionyl-tRNA synthetase were purified in our
laboratory by Mike Dyson. Nuclease P1, modified trypsin (sequencing
grade), and chymotrypsin (sequencing grade) were obtained from
Boehringer Mannheim. RNase T1 was from Sankyo Chemical Company Ltd.
(Tokyo, Japan). [35S]Methionine (specific activity = 1175 Ci/mmol) and [
-32P]ATP (specific activity = 3000 Ci/mmol) were purchased from DuPont NEN. All of the solvents used
for HPLC were HPLC grade and procured from EM Science. All other
routinely used chemicals were of the highest purity grade
available.
The reaction was carried out at 37 °C. The incubation mixture (20 µl) contained 20 mM imidazole-HCl buffer (pH 7.5), 0.1 mM EDTA, 2 mM ATP, 150 mM NH4Cl, 10 µg/ml bovine serum albumin, 4 mM MgCl2, 25 µM [35S]methionine (specific activity = 5,000-10,000 cpm/pmol), tRNA (approximately 0.1 A260 of total tRNA or 0.01 A260 of pure tRNAfMet) and saturating amounts of purified methionyl-tRNA synthetase. Aliquots (5 µl) were withdrawn at 5-min intervals and spotted onto 3 MM Whatman paper discs (presoaked in 5% trichloroacetic acid and dried), and the discs were washed for 20 min at 0 °C, followed by a wash with 5% trichloroacetic acid (10 min) and finally one wash with ethanol for 10 min (22). Discs were dried in a ventilation oven, and the radioactivity on each filter was determined by scintillation counting.
Assay for Formylation of Met-tRNAfMetThe incubation (20 µl), carried out at 37 °C, contained 10 µl of the above aminoacylation reaction mixture (which had been preincubated for 30 min), 0.3 mM N10-formyltetrahydrofolate, and appropriate amounts of MTF (depending on the purity and specific activity of preparation). The reaction was allowed to proceed for 15 min and was terminated by the addition of 20 µl of 0.36 M CuSO4 in 1.1 M Tris-HCl (pH 7.3) and incubated further for 3 min at room temperature (20). Acid-precipitable radioactivity was measured as described for the aminoacylation assay.
Purification of MTFPurification of MTF was carried out using a procedure developed by Dr. D. Mangroo.3 The specific activity of the purified enzyme was 2.69 × 105 pmol of formyl group incorporated into Met-tRNAfMet/min/µg of protein. The purified enzyme migrated as a single band on SDS-polyacrylamide gels.
Analytical MethodsProtein concentrations were estimated by
the modified Lowry DC method as described by the supplier (Bio-Rad)
using IgG as a standard. The concentration of purified MTF was also
determined using an absorbance of 1.39 at 280 nm for a solution
containing 1 mg/ml of MTF and with a light path of 1 cm (23). This
value agreed well with the value obtained from the Bio-Rad protein
assay. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out according to Laemmli (24) after boiling the protein samples for 5 min in 62.5 mM Tris-Cl, pH 6.8, containing 4% (w/v) SDS, 10% glycerol, 10% -mercaptoethanol, and 0.02% bromphenol
blue.
Total tRNA was isolated by phenol extraction
from E. coli cells (17 g, wet weight) overproducing
tRNA2fMet from the plasmid pUC13 trnfM
(which carries the tRNA2fMet gene).
The crude tRNA (100 A260 units) was fractionated
on a 10% native polyacrylamide gel, and tRNAs were visualized by UV shadowing (25). The gel slice containing tRNAfMet was cut,
and tRNAfMet was eluted from the gel in 20 mM
Tris-HCl buffer, pH 8.0, containing 1 mM EDTA (TE buffer).
The purity of gel-eluted tRNAfMet, estimated by
polyacrylamide gel electrophoresis and by aminoacylation assay, was
>95% (22). 32P-3-End labeling of tRNAfMet
was carried out using tRNA nucleotidyltransferase. First, the 3
-terminal A76 was removed by Whitfeld degradation by treatment of the
tRNA with sodium periodate and subsequently with aniline (26). The
3
-terminal phosphate thus generated was removed by treatment with
alkaline phosphatase. The reaction mixture for 3
labeling contained 50 mM glycine-NaOH (pH 9.2), 10 mM
Mg(OAc)2, 10 mM glutathione-SH, 10 µg/ml
bovine serum albumin, 50 µM [
-32P]ATP, 6 µM tRNAfMet (
A76) and 2 units of E. coli tRNA nucleotidyltransferase. Incubation was at 37 °C for
20 min. One unit of tRNA nucleotidyltransferase is the amount of enzyme
that catalyzes the incorporation of 1 µmol of AMP/h (27). Unreacted
ATP was removed by spin column chromatography through a 1-ml Sephadex
G-25 column. The 32P-3
-end-labeled tRNAfMet
was recovered by ethanol precipitation and dissolved in 20 µl of TE
buffer (pH 8.0). The labeled tRNAfMet was subsequently
purified by denaturing polyacrylamide gel electrophoresis (8 M urea-PAGE), eluted from gel, and precipitated with
ethanol. The pellet was dried and dissolved in distilled water and
stored at
20 °C.
The
reaction mixture (40 µl) contained 1.0 A260
unit of 3-end labeled [32P]tRNAfMet (30,000 cpm), 2.5 mM sodium periodate, and 100 mM
sodium acetate, pH 5.2. The reaction was carried out for 30 min at
0 °C in the dark. Excess periodate was destroyed by the addition of
ethylene glycol to 5 mM (final concentration). The oxidized
tRNAfMet was ethanol-precipitated, the pellet was dissolved
in water, 0.1 volume of 3 M sodium acetate buffer, pH 5.0, was added to it, and the oxidized tRNAfMet was
reprecipitated with ethanol. The pellet was collected by centrifugation, excess ethanol was removed, and the pellet was dried
and dissolved in 50 µl of distilled water and used immediately for
the cross-linking reaction. The extent of oxidation of
tRNAfMet was checked by determining the residual methionine
acceptance activity (22) of oxidized tRNA and was found to be
essentially complete (>96%).
For most experiments, the periodate-oxidized tRNAfMet (10 pmol) was incubated in a total volume of 10 µl with MTF (0.066 µg, 2 pmol) in 20 mM imidazole-HCl, pH 7.5, 10 mM MgCl2, and 0.1 mM EDTA at 37 °C for 1 h in the presence of 1 mM sodium cyanoborohydride (21). The reaction was quenched by the addition of sodium borohydride (1 mM final concentration), and the extent of cross-linking was determined by SDS-PAGE followed by autoradiography and quantitation by PhosphorImager analysis. The effect of the addition of either excess substrate (tRNAfMet) or cofactor (N10-formyltetrahydrofolate) to the reaction mixture on the cross-linking efficiency was determined by adding appropriate amounts of these ligands to the reaction mixture followed by incubation for 10 min at 37 °C prior to the addition of periodate-oxidized tRNAfMet. The effect of cross-linking of periodate-oxidized tRNAfMet to MTF on the enzymatic activity of MTF was evaluated by withdrawing (5 µl) aliquots of a large scale reaction mixture (60 pmol of MTF and 300 pmol of either 32P-labeled unoxidized initiator tRNA or oxidized initiator tRNA) at various times (every 5 min for 30 min) and estimating the residual enzyme activity after diluting the reaction mixture 500-fold with 20 mM imidazole buffer, pH 7.5, containing 10 mM MgCl2 and 0.1 mg/ml bovine serum albumin. For isolation and analysis of cross-linked MTF, a large scale reaction was carried out using 20 µg of MTF (600 pmol) and 1800 pmol of periodate-oxidized tRNAfMet (3-fold molar excess), and the reaction time was increased to 2 h.
Rate of Cross-linking of Various tRNAs to MTFMTF (90 pmol) in 40 µl of 20 mM imidazole-HCl, pH 7.5, 10 mM MgCl2, and 0.1 mM EDTA was incubated with 450 pmol of oxidized tRNAs in the presence of 1 mM sodium cyanoborohydride at 37 °C. Aliquots (4 µl) were removed at the indicated time intervals, and the reaction was quenched by the addition of 1 µl of sodium borohydride (final concentration of 1 mM). The extent of cross-linking in each case was determined by SDS-PAGE followed by autoradiography and by PhosphorImager analysis.
Separation of the Cross-linked MTF from MTF and Digestion of the tRNA Moiety in the Cross-linked MTFMTF cross-linked to tRNA was separated from uncross-linked MTF by DEAE-cellulose chromatography. Following the cross-linking reaction, the reaction mixture was diluted to 1 ml with 0.1 M Tris-HCl, pH 7.5, containing 0.2 M LiCl and loaded onto a DEAE-cellulose column (1 ml) preequilibrated with the same buffer. After extensive washing of the column to remove MTF, the cross-linked MTF was eluted with 0.1 M Tris-HCl, pH 7.5, containing 1 M LiCl. Fractions (0.3 ml) were collected. The fractions showing high radioactivity were pooled and subjected to Centricon-10 ultrafiltration for desalting. After centrifugation, excess tRNA and tRNA cross-linked to MTF was hydrolyzed to nucleotides (28) by incubating the cross-linked MTF with 0.3 unit of P1 nuclease and 5 units of RNase T1 at 45 °C for 4 h. The extent of hydrolysis of tRNA from cross-linked MTF was analyzed by SDS-PAGE and autoradiography.
To remove free nucleotides from cross-linked MTF, the reaction mixture with nuclease P1 and RNase T1 was subjected to gel filtration on a Sephadex G-50 column (0.8 × 14 cm). Fractions containing MTF (void volume) were concentrated and used for proteolytic digestion. Alternatively, centrifugation through the Centricon-10 membrane was used to remove the released nucleotides from cross-linked MTF.
Trypsin Digestion of Cross-linked MTF and Separation of Peptides by HPLCThe cross-linked MTF (20 µg and ~10,000 cpm of Cerenkov radiation) in 100 µl of 100 mM Tris-HCl, pH 7.5, was treated with 2 µg of sequencing grade modified trypsin (10%, w/w) at 37 °C for 12 h. The tryptic peptides were separated by HPLC on a Hewlett-Packard HP-1090 HPLC system equipped with a reverse phase Vydac C18 column (0.46 × 25 cm). The trypsin digest was diluted with 0.1% trifluoroacetic acid in water to 250 µl, centrifuged at 14,000 rpm, and injected into the column preequilibrated with 90% solvent A (0.1% trifluoroacetic acid in water) and 10% solvent B (0.1% trifluoroacetic acid in 100% acetonitrile). The elution rate was 0.5 ml/min in 90% solvent A and 10% solvent B from 0 to 10 min followed by a linear gradient from 10% solvent B to 20% solvent B between 10 and 60 min (0.2% per min) and then 20-27% B between 60 and 160 min (0.07% per min) and then 27-100% solvent B in an additional 40 min (1.82% per min). The effluent was continuously monitored at 210 nm, and fractions of 0.5 ml were collected. The radioactivity in each fraction was determined by Cerenkov counting for 32P in an LKB-1217 RACKBETA liquid scintillation counter.
Chymotrypsin Digestion of Peak II* and HPLCFractions containing peak II* (obtained from the HPLC of trypsin digestion of cross-linked MTF above) were lyophilized and dissolved in 100 µl of 100 mM Tris-HCl, pH 7.5. This mixture was then treated with 2 µg of chymotrypsin for 5 h at 37 °C and subjected to reverse phase HPLC on a C18 column. The column was preequilibrated with 100% solvent A. The elution rate was 0.5 ml/min in 100% solvent A from 0 to 10 min followed by a linear gradient from 0 to 25% Solvent B between 10 and 135 min (0.2% per min) and then 25-100% Solvent B for an additional 35 min. The effluent was continuously monitored at 210 nm, and fractions of 0.5 ml were collected. The radioactivity in each fraction was determined by Cerenkov counting for 32P as above.
Mass Spectroscopic Analysis and Amino Acid Sequencing of Radioactive PeptidesThe mass of the cross-linked peptides was
determined on a MALDI mass spectrophotometer (PerSeptive Biosystems
Voyager mass spectrophotometer) using delayed extraction technology.
For the mass analysis of the peptides, approximately 1 pmol of peptide (based on radioactivity) was mixed with 1 µl of
-cyano-4-hydroxycinnamic acid (matrix). For calibration of the mass
spectrophotometer, oxidized insulin chain B (Sigma)
was used as a standard. C-terminal amino acid sequencing was also
carried out using limited digestion of peptide with carboxypeptidase Y
followed by mass spectroscopic analysis. The N-terminal amino acid
sequence of isolated peptides was determined using an automated gas
phase protein/peptide sequence analyzer from Applied Biosystems (model
470A) equipped with an on-line phenylthiohydantoin analyzer (model 120)
and computer (model 900A).
Periodate-oxidized nucleotides
and tRNAs have often been used as affinity reagents for cross-linking
to proteins (29). Oxidation of tRNA with sodium periodate converts the
terminal ribose moiety in the A76 of the tRNA to a 2,3
-dialdehyde.
The dialdehyde then reacts primarily with the
-amino group of lysine
residues in a protein that comes close to the 3
-end of tRNA.
For following the cross-linking of MTF to the tRNA,
32P-3-end-labeled tRNA2fMet
was incubated with MTF in the presence of sodium cyanoborohydride, which reduces the intermediate Schiff's base and prevents reversal of
the reaction (21). The reaction was quenched after 1 h by the
addition of sodium borohydride, and the products were analyzed by
SDS-polyacrylamide gel electrophoresis followed by autoradiography of
the gel. Fig. 2, lane 2, shows that in an
incubation mixture containing periodate-oxidized tRNA, most of the
32P radioactivity migrated more slowly than tRNA at a
position expected for that of a tRNA cross-linked to a protein.
Formation of the tRNA-protein cross-link requires oxidation of the tRNA
with periodate. When 32P-3-end-labeled
tRNA2fMet without periodate oxidation
was incubated with MTF under identical conditions, there was no
cross-link between the tRNA and the protein (Fig. 2, lane
1). The presence of sodium cyanoborohydride during the incubation
was found to be important for maximal cross-linking (data not
shown).
Fig. 3 shows the effect of increasing the concentration
of the oxidized tRNA on the extent of cross-linking. It can be seen that with 2 pmol of MTF (0.2 µM), the extent of
cross-linking is dependent on the concentration of the tRNA and reaches
a plateau at approximately 10-20 pmol of the tRNA (1-2
µM). This result indicates that the cross-linking of
periodate-oxidized tRNA2fMet to MTF is
saturable and that it is quite specific. Further evidence for the
specificity of cross-linking was derived from an experiment in which
increasing amounts of unoxidized
tRNA2fMet was added to the cross-linking
reaction containing a fixed amount of periodate-oxidized tRNA. It was
found that there was a gradual decrease in the extent of cross-linking
dependent upon the concentration of unoxidized
tRNA2fMet in the reaction (data not
shown). This result suggests that unoxidized tRNA and oxidized tRNA are
competing for the same site in MTF. In contrast, the addition of
N10-formyltetrahydrofolate, another
substrate of MTF, had no significant effect on the extent of
cross-linking (data not shown).
The cross-linking of MTF to periodate-oxidized tRNA2fMet leads to loss of enzymatic activity of MTF. Incubation of MTF with periodate-oxidized tRNA2fMet leads to a time-dependent inactivation of MTF (data not shown). This inactivation requires the presence of periodate-oxidized tRNA2fMet. The presence of a 10-fold excess of unoxidized tRNA2fMet over the oxidized tRNA, which competes against cross-linking of MTF to the oxidized tRNA, also protects MTF from inactivation (data not shown). A similar effect of cross-linking of oxidized tRNAfMet on enzymatic activity of MTF was described before by Hountondji et al. (21).
Identification of Amino Acid(s) in MTF Cross-linked to tRNA2fMetThe following strategy
was used to isolate and analyze the peptide(s) attached to the tRNA.
Following the cross-linking reaction, cross-linked MTF was separated
from uncross-linked MTF by DEAE-cellulose chromatography (see
"Materials and Methods"). The excess of
32P-3-end-labeled tRNA2fMet
and most of the tRNA moiety in the cross-linked MTF were hydrolyzed to
nucleotides using a mixture of nuclease P1 and RNase T1. A mixture of
the two nucleases was used to ensure complete hydrolysis of the tRNA
(28). This treatment should yield MTF carrying only a
32P-labeled fragment of AMP attached to it. The
cross-linked MTF carrying the 32P label was separated from
the mononucleotides and digested with trypsin, and the tryptic peptides
were separated by high pressure liquid chromatography (HPLC). A similar
tryptic digest of MTF that had not been cross-linked to tRNA was also
subjected to HPLC.
Fig. 4 shows the tryptic peptide and 32P
radioactivity profiles of MTF and MTF cross-linked to
[32P]AMP moiety of the tRNA. A peptide peak (designated
peptide I) eluting at 66 min in digests of MTF (Fig. 4A), is
absent in digests of cross-linked MTF (Fig. 4B) and is
replaced in the latter by a peak (designated peptide I*) eluting at 104 min. This peptide I*, which is absent in digests of uncross-linked MTF,
also contains 32P radioactivity (Fig. 4C),
suggesting that it is derived from the peptide eluting at 66 min in
digests of uncross-linked MTF. Another peak designated peptide II* also
contains 32P radioactivity. This peak contains a mixture of
two peptides, one of which is radioactive. We show below that the
radioactive peptide II* is a partial digestion product and is the same
as peptide I* but with an extension of four amino acids at the C terminus.
Characterization of Peptides I and I*
A combination of MALDI mass spectroscopy (30), N-terminal sequencing using Edman degradation (31), and C-terminal sequencing using partial digestion with carboxypeptidase Y (32) followed by MALDI mass spectroscopic analysis was used to establish the sequence of these peptides. The following lines of evidence summarized in Table I show that peptide I* has the sequence 186QLADGTAKPEVQDETLVTYAEKLSK210, in which Lys207 is linked to the [32P]AMP moiety of the tRNA.
|
(i) MALDI mass spectroscopy of peptide I yielded two peaks with molecular masses of 2406.95 and 2390.59 Da. The only tryptic peptide of MTF that fits this is Gln186-Lys207. The difference of 16.36 Da in the two molecular masses is most probably due to the well known conversion of glutamine at the N terminus of peptides or proteins to pyroglutamic acid (33). The complete absence of a peak corresponding to peptide I in digests of cross-linked MTF (Fig. 4B) suggests that one of the two lysine residues in the peptide is linked to the AMP moiety of the tRNA. The most likely possibility is that Lys207 is cross-linked to the AMP moiety, thereby making the peptide bond involving this lysine residue resistant to cleavage by trypsin in the cross-linked MTF.
(ii) N-terminal sequencing of peptide I* yielded the sequence QLADGTAKPE, which is the same as that of peptide I. This result confirms the suggestion above that peptide I* is derived from peptide I. Furthermore, the clear identification of lysine as amino acid number 8 of peptide I* shows that lysine 193 is not cross-linked in MTF and supports the conclusion above that Lys207 is the one most probably cross-linked. While the N-terminal sequence data were unambiguous, the yields of phenylthiohydantoin-derivatives in the first and successive cycles were much lower than expected (~35%), based on the 32P radioactivity present in peptide I*. This is due to the fact that most of the glutamine at the N terminus is converted to pyroglutamic acid, which is inert to the reagents used for N-terminal sequencing.
(iii) Partial digestion with carboxypeptidase Y of peptide I* in situ on the sample plate used for MALDI mass spectroscopy, followed by mass spectroscopic analysis of the partial digestion products, indicated the loss successively of the amino acids lysine, serine, and leucine from the C terminus. Thus, the sequence at the C terminus of peptide I* is -LSK. These are the amino acids that immediately follow Lys207 in the sequence of MTF. This result supports the conclusion above that peptide I* is derived from peptide I and shows that it has an extension of LSK at the C terminus beyond Lys207.
(iv) Final evidence for the sequence of peptide I* was derived by MALDI
mass spectroscopic analysis. Mass spectroscopy yielded four peaks with
molecular masses in decreasing order of 3052.23, 3035.31, 2917.37, and
2901.09 daltons (Fig. 5). The molecular mass of 3052.23 Da is very close to that expected for the cross-linked peptide
Gln186-Lys210, in which Lys207 is
cross-linked to the AMP moiety of the tRNA (Table I). The peptide with
mass of 3035.31 Da differs from the previous one by 16.92 Da and most
likely has pyroglutamic acid at the N terminus instead of Gln in the
former. The peptides with masses of 2917.37 and 2901.09 Da differ from
the above two, respectively, by masses of ~134-135 Da and correspond
to those peptides in which the adenine base of AMP has fragmented off
during mass spectroscopy (34).
Molecular mass measurement of three different isolates of peptide I*
yielded values of 3052.23, 3049.19, and 3050.66 Da. The average
molecular mass of 3050.7 Da thus obtained for peptide I* differs by
only about 2.2 Da from the molecular mass expected for a cross-linked
product, which contains a morpholino type of linkage (Fig.
6, III) between the peptide and the
ribose moiety of AMP rather than a reduced Schiff's base (Fig.
6, I).
Characterization of Peptide II*
MALDI mass spectroscopic analysis of peptide II* showed that it contained a mixture of peptides with molecular masses of 2641.47 and 3536.71 Da. The peptide with a molecular mass of 2641.47 Da was shown to have the sequence 19HLDALLSSGHNVVGVFTQPDRPAGR43 by N- and C-terminal sequence analysis. This peptide is also present in digests of uncross-linked MTF (Fig. 4A). The radioactive peptide II* with a molecular mass of 3536.71 Da was established by the following three lines of evidence to have the same sequence as peptide I* except that it has an extension at the C terminus of EEAR.
(i) Peptide II* was treated with chymotrypsin, and the digest was
subjected to HPLC chromatography (Fig. 7). A predominant radioactive peak that coeluted with a peptide peak was obtained. This
peptide was then used for sequence analysis using Edman degradation, the products of each cycle being also monitored for release of 32P radioactivity.
(ii) Fig. 8 shows that the sequence of the chymotryptic
peptide is AEXLSKEEAR, in which X in the third
cycle (corresponding to Lys207 in uncross-linked MTF)
contains most of the 32P radioactivity. This peptide
sequence overlaps with the C-terminal sequence of peptide I*. These
results establish that Lys207 is the site of cross-linking
of MTF to the 3-end of tRNA2fMet. The
yield of amino acid in the first and most of the successive cycles was
at least 50% of that expected on the basis of 32P
radioactivity present.
(iii) Finally, as for peptide I*, the observed molecular mass of
3536.71 Da for peptide II* differs by only ~3 Da from the mass of
3533.66 Da expected for a peptide
Gln186-Arg214, in which Lys207 is
attached through a morpholino type of linkage (Fig. 6, III) to the AMP moiety derived from the 3-end of the tRNA.
Although MTF formylates only the
initiator methionyl-tRNA species (15), previous studies have shown that
it will nevertheless bind to other tRNAs almost as well as to the
initiator tRNA (35). Therefore, we have investigated whether the
periodate-oxidized G72 mutant of
tRNA2fMet, which is a very poor
substrate for MTF (16-18), and yeast tRNAPhe, which is not
a substrate for MTF, will cross-link to MTF. Fig. 9
shows the results. While all three tRNAs react with MTF, the rate of
cross-linking with tRNA2fMet is
significantly higher than with the mutant
tRNA2fMet or yeast tRNAPhe.
The reaction with tRNA2fMet reaches a
plateau after 1 h, whereas even after 2 h the reactions with
the other tRNAs have not reached the level attained with tRNA2fMet. These results are in
agreement with those of Hountondji et al. (21), who showed
that the rate of reaction of periodate-oxidized yeast
tRNAPhe with MTF, as followed by inactivation of MTF, was
about 6-fold lower than that of tRNAfMet.
The site(s) of cross-linking of the G72 mutant of tRNA2fMet and yeast tRNAPhe were also analyzed by HPLC of tryptic digests of MTF cross-linked to these tRNAs. The same two radioactive peaks as seen above for cross-linking of wild type tRNA2fMet to MTF were found (data not shown). Thus, the mutant tRNA2fMet and the yeast tRNAPhe also cross-link to Lys207 in MTF.
As a first step in studies on the topology of interaction of
E. coli initiator tRNA with MTF, we have shown that reaction of periodate-oxidized tRNA with MTF leads to cross-linking of the tRNA
specifically to Lys207 of the enzyme. This suggests that
Lys207 comes close to the 3-end of the tRNA. Since MTF
formylates the amino group of methionine attached to the 3
-end of the
tRNA, Lys207 is likely to be within or near the active site
of the enzyme.
The Lys207 of MTF is part of the sequence
207KLSKE211. This sequence is related to a
similar sequence, KMSKS or KLSKS, found in virtually all class I
aminoacyl-tRNA synthetases (36). The significance, if any, of this
similarity in sequences is not known. In two of the E. coli
class I aminoacyl-tRNA synthetases, tyrosyl-tRNA synthetase and
methionyl-tRNA synthetase, one or the other of the lysine residues in
the KMSKS or KLSKS sequence has been shown to cross-link to the 3-end
of the corresponding periodate-oxidized tRNA (37, 38). These lysine
residues are also functionally important for stabilization of the
ground state and/or the transition state during the formation of
aminoacyl-adenylate (36, 39, 40). In a class II aminoacyl-tRNA
synthetase also, a lysine residue that cross-links to the 3
-end of
periodate-oxidized tRNA is part of a conserved motif (motif 2)
important for aminoacyl-adenylate formation and for transfer of the
amino acid to the tRNA (41, 42). Whether Lys207 or
Lys210 plays a functional role in MTF is not known.
Although these amino acid residues lie within a conserved region in the
six MTF protein sequences deduced on the basis of DNA sequences (Fig.
10), Lys207 is present in E. coli, Hemophilus influenzae and Rickettsia
prowazekii MTF but not in Thermus thermophilus,
Mycoplasma genitalium, or yeast mitochondrial MTF.
Another region of very strong sequence conservation in MTF includes amino acids 83-150. This region contains amino acids Asn109, His111, and Asp147, thought to be involved in catalysis (43, 44) in E. coli glycinamide ribonucleotide formyltransferase, another enzyme that, like MTF, transfers a formyl group using N10-formyltetrahydrofolate as a cofactor (45). These three amino acids are conserved in all six of the MTF sequences known so far. The strict conservation of these amino acid residues in MTF and the very strong homology in this region among MTF, the glycinamide ribonucleotide formyltransferases, and amino imidazole carboxamide ribonucleotide formyltransferases (46, 47) from a number of sources suggest that these amino acids also play a similar catalytic role in MTF. If, as stated above, Lys207 is at or near the active site of the MTF, it might be close to amino acids 109, 111, and 147 in the three-dimensional structure.
Reaction of periodate-oxidized G72 mutant initiator tRNA, which is a
very poor substrate for MTF and yeast tRNAPhe, also led to
cross-linking to MTF, although at a slower rate compared with the wild
type initiator tRNA. This result agrees with the previous observation
that although MTF formylates only the initiator methionyl-tRNA species,
it binds almost as well to other tRNAs with dissociation constants in
the micromolar range. The site of cross-linking to the mutant initiator
tRNA and to yeast tRNAPhe is also Lys207. It
would thus appear that MTF has a binding pocket for the 3-end of the
tRNA and that all of these tRNAs bind initially to MTF in a similar
manner. The differences in rates of reaction of MTF with cognate
versus noncognate tRNA or the G72 mutant initiator tRNA
could be due to a conformational change, subsequent to binding, of the
MTF-cognate tRNA complex, which places Lys207 of MTF in a
favorable position for reaction with the 3
-end of the tRNA in the
cognate complex. Evidence for a possible conformational change of the
cognate tRNA upon binding to MTF has been obtained by NMR analysis of
MTF complexed to initiator and elongator species of methionine tRNA
(35). NMR analysis showed a general broadening and loss of intensity of
resonances assigned to G:C base pairs in the acceptor stem of the
initiator tRNA species but not of the elongator tRNA species. The
notion of a conformational change in the MTF-initiator tRNA complex
subsequent to binding is similar to the situation with aminoacyl-tRNA
synthetase-tRNA complexes in which a conformational change of the
complex is triggered by cognate tRNAs but not by noncognate tRNAs
(48).
Another explanation for the cross-linking of all three tRNAs to
Lys207 of MTF is that Lys207 is just a
particularly reactive lysine residue in MTF. We consider this unlikely.
First, the periodate-oxidized initiator tRNA does not react with just
any protein. For example, it does not react with bovine serum albumin
(data not shown). Second, we have also cross-linked periodate-oxidized
E. coli 5 S rRNA carrying a 3-terminal 32P-pC
extension to MTF and analyzed the tryptic digest of the cross-linked MTF by HPLC. In contrast to the specific cross-linking of the 3
-ends
of tRNAs to Lys207, there were several other radioactive
peptides in the tryptic digest of MTF cross-linked to 5 S RNA (data not
shown).
Mass spectral analysis of peptides derived from MTF that were
cross-linked to the AMP moiety of the tRNA has proven extremely useful
in the characterization of the cross-linked peptides and the nature of
the cross-link formed. Earlier reports on the reaction of
2,3
-dialdehydes derived by periodate oxidation of tRNA, nucleosides, or 5
-mononucleotides with primary amines indicated the production of
either a Schiff's base (Fig. 6, I) or a morpholino
derivative in which one of the carbon atoms in the morpholine ring
carries a hydroxyl group (49) (Fig. 6, II). The molecular
masses that we have obtained for the cross-linked peptides are,
however, more consistent with a morpholino derivative described by
Brown and Read (50) in which none of the carbon atoms in the morpholine ring carries a hydroxyl group (Fig. 6, III). A possible
mechanism for the formation of this is that the secondary amine formed
by reduction of the Schiff's base intermediate with sodium
cyanoborohydride attacks the neighboring carbonyl group, leading to the
formation of a morpholine ring. Loss of water followed by reduction
with sodium cyanoborohydride or sodium borohydride would generate the morpholino derivative III shown in Fig. 6.
Finally, the work described here has provided the first indication of
the amino acid residue in MTF that comes close to the 3-end of the
tRNA. In parallel work, we are attempting isolation and identification
of suppressor mutations in MTF that compensate for formylation defects
of mutant initiator tRNA. The information derived from these
experiments, along with knowledge of the amino acid residues in MTF
that are highly conserved (Fig. 10), can be used for the selection of
amino acid residues in MTF for site-specific mutagenesis and
structure-function relationship studies.
We dedicate this paper to Professor Nelson J. Leonard on the occasion of his eightieth birthday.
We thank Dr. Paul Matsudaira for mass spectroscopic analysis and for sequence analysis of the peptides, Dr. H. Gobind Khorana for comments and suggestions during this work, and Dr. Paul Schimmel for helpful comments on the manuscript. We thank our colleagues Dr. Louise Hancox for the initial work on Whitfeld degradation of tRNAs and for guidance in initiation of this project, Dr. Dev Mangroo for developing a method for the overproduction and purification of MTF and for guidance in its purification, and Dr. Mike Dyson for purification of E. coli methionyl-tRNA synthetase, the E. coli tRNA nucleotidyltransferase, and the G72 mutant of initiator tRNA. We thank Annmarie McInnis for care and cheerfulness in the preparation of this manuscript.
The crystal structure of E. coli
MTF has been published recently (Schmitt, E., Blanquet, S., and
Mechulam, Y. (1996) EMBO J. (1996) 15, 4749-4758). The crystal structure shows that Lys207
is on the surface of the protein and is part of a positively charged
channel possibly involved in orientation of the acceptor stem of
Met-tRNA toward the active site. The specific cross-linking of
Lys207 to the 3-terminal A of tRNAfMet
described in this paper is consistent with such a possibility.